Using GIS Dashboards to highlight AMR data disparities in Africa for Policy, Research, and Public Health
This study integrates fragmented antimicrobial resistance (AMR) surveillance data from private, public, and academic sources across Africa into interactive GIS dashboards to visualize disparities in reporting and infrastructure, thereby providing a unified evidence base to guide policy, research, and public health interventions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine the world's bacteria as a massive, invisible army. For decades, we've had a powerful weapon against them: antibiotics, the "magic bullets" that cure infections. But just like in a video game where enemies evolve to beat your best moves, these bacteria are learning to fight back. This is called Antimicrobial Resistance (AMR). When bacteria become resistant, the drugs stop working, turning minor infections into life-threatening battles. To win this war, doctors and scientists need a clear map of where the resistance is strongest, which drugs are failing, and which countries are missing from the map entirely. However, right now, the information about this invisible war is scattered. Some data is locked in private labs, some is in government reports, and some is hidden inside academic papers. It's like trying to solve a giant jigsaw puzzle when the pieces are spread across three different houses, and some pieces are missing entirely. Without a complete picture, it's hard to know where to send help or how to stop the spread.
This paper is like a team of digital detectives who decided to build a giant, interactive "Google Maps" for these scattered puzzle pieces. The researchers, led by Wendy Akushika Dogbegah and her colleagues, gathered data from three very different sources: private pharmaceutical companies (who test drugs during development), public health organizations (like the WHO), and academic studies published by scientists. They took all these messy, disconnected datasets and stitched them together into a single, colorful, interactive dashboard. Think of it as a high-tech control room where you can zoom in on any African country, click on a specific year, and instantly see a visual story of which bacteria are resisting which drugs.
The big discovery? The map is incredibly lopsided. When they looked at the data, they found that a tiny handful of countries were doing almost all the reporting. For instance, in the public data they analyzed, South Africa alone contributed 488,511 bacterial samples, which was a massive 60.87% of the total. In the private data, South Africa again led the pack with 20,103 samples, or 63.20% of that total. Meanwhile, countries like Sierra Leone and Mozambique had almost no data at all, contributing less than 0.05% each. The authors suggest that this doesn't necessarily mean those countries have fewer resistant bacteria; it likely means they have fewer labs, less funding, or weaker systems to count the bacteria. It's a "visibility bias"—just because you can't see the fire doesn't mean it isn't burning.
The paper also argues against the idea that we can simply compare the raw numbers from these different sources to see who has the "worst" resistance. Because the private and public groups used different testing methods, different time periods, and different rules for counting, the authors explicitly state that you cannot treat these numbers as a direct race. You can't say Country A is "worse" than Country B just because the dashboard shows more red dots for Country A; the dots might just be there because Country A has a better camera.
However, the tool they built is a game-changer for spotting the gaps. By visualizing the data, they showed that while some countries are loud and clear, many are silent. They also found that academic research papers often hold the missing pieces for countries that aren't in the big government or private databases. The dashboard allows users to filter by country, year, or specific bacteria (like E. coli or Pseudomonas), revealing patterns that were previously hidden in spreadsheets. For example, they could see that certain drugs like Ampicillin were failing across many places, while others like Imipenem were still working well in some spots.
Ultimately, the authors are careful to say this dashboard isn't a real-time alarm system that will instantly stop an outbreak. It's a "surveillance-support tool"—a way to explore the data, ask better questions, and figure out where to build more labs or send more training. It suggests that to truly fight AMR in Africa, we need to stop looking at the data that's easy to get and start shining a light on the countries that are currently invisible on the map. By making these gaps visible, the dashboard hopes to help policymakers and researchers decide where to invest their resources to ensure that no one is left fighting the invisible army without a map.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.